OR WAIT null SECS
© 2024 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
March 02, 2004
Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.
Selecting a buffer for the formulation of a protein requires an understanding of the potential effects of various buffers on protein stabilization.
Protecting a product from temperature abuse is gaining importance as regulators seek proof of product stability throughout the distribution process.
Erythrocytes, the most abundant cells in the human body, have potential carrier capabilities for the delivery of drugs.
The need to provide both operator and product protection while developing more efficient containment strategies has initiated a wave of innovative solutions in barrier/isolation equipment design and implementation.
Companies that leverage new collaborative technologies in the manufacture, packaging, and distribution of clinical trial materials will be best positioned to reduce their time to market.
Pharmaceutical science and technology news
As outsourcing services become a more integral part of pharmaceutical processes, drug companies are taking a harder line on consequential.